trial · primary record
Biocidin REMOVE
Irritable Bowel Syndrome (IBS)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Proportion of Participants With Remission of Small Intestinal Bacterial Overgrowth |
| Registry ID | NCT07768267 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:34.005Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07768267
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.